Chapters

Transcript

Video

In the second phase of the CAHtalyst pediatric trial, can you discuss initiating down-titration of glucocorticoid therapy, and what levels of glucocorticoid sparing were targeted?

In the second phase of the CAHtalyst pediatric trial, can you discuss initiating down-titration of glucocorticoid therapy, and what levels of glucocorticoid sparing were targeted?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Phyllis W. Speiser, MD

Phyllis W. Speiser, MD

Associate Professor, Institute of Molecular Medicine
Feinstein Institutes for Medical Research
Emerita Professor, Pediatrics Donald and Barbara Zucker School of Medicine
Hofstra/Northwell
New Hyde Park, NY